Healthcare provider profile · identity verified

Peter Lee Sone, M.D.

Family Practice · OAK HARBOR, WA · NPI 1417268780

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	624	227
Losartan Potassium	Losartan Potassium	370	127
Amlodipine Besylate	Amlodipine Besylate	322	123
Levothyroxine Sodium	Levothyroxine Sodium	255	89
Lisinopril	Lisinopril	247	92
Tamsulosin Hcl	Tamsulosin Hcl	218	70
Metoprolol Succinate	Metoprolol Succinate	189	70
Gabapentin	Gabapentin	186	61
Albuterol Sulfate Hfa	Albuterol Sulfate	176	114
Atenolol	Atenolol	165	54
Hydrochlorothiazide	Hydrochlorothiazide	159	57
Pantoprazole Sodium	Pantoprazole Sodium	153	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	151	40
Prednisone	Prednisone	140	73
Metoprolol Tartrate	Metoprolol Tartrate	123	44
Fluticasone Propionate	Fluticasone Propionate	117	41
Simvastatin	Simvastatin	113	44
Furosemide	Furosemide	109	47
Metformin Hcl Er	Metformin Hcl	104	42
Metformin Hcl	Metformin Hcl	101	35
Finasteride	Finasteride	91	31
Meloxicam	Meloxicam	87	40
Breyna	Budesonide/Formoterol Fumarate	81	29
Allopurinol	Allopurinol	79	32
Famotidine	Famotidine	77	33
Trazodone Hcl	Trazodone Hcl	77	35
Azelastine Hcl	Azelastine Hcl	74	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	28
Omeprazole	Omeprazole	73	28
Baclofen	Baclofen	71	36
Ibuprofen	Ibuprofen	70	29
Montelukast Sodium	Montelukast Sodium	70	28
Potassium Chloride	Potassium Chloride	69	26
Alendronate Sodium	Alendronate Sodium	68	22
Alvesco	Ciclesonide	66	21
Nabumetone	Nabumetone	63	30
Tramadol Hcl	Tramadol Hcl	62	23
Sertraline Hcl	Sertraline Hcl	60	20
Pradaxa	Dabigatran Etexilate Mesylate	58	20
Glipizide	Glipizide	57	22
Jardiance	Empagliflozin	57	23
Escitalopram Oxalate	Escitalopram Oxalate	54	19
Terazosin Hcl	Terazosin Hcl	50	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	14
Clobetasol Propionate	Clobetasol Propionate	46	34
Citalopram Hbr	Citalopram Hydrobromide	43	11
Rosuvastatin Calcium	Rosuvastatin Calcium	42	17
Duloxetine Hcl	Duloxetine Hcl	41	19
Triamcinolone Acetonide	Triamcinolone Acetonide	41	19
Ropinirole Hcl	Ropinirole Hcl	40	14
Donepezil Hcl	Donepezil Hcl	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	17
Hydralazine Hcl	Hydralazine Hcl	38	16
Lovastatin	Lovastatin	38	14
Rizatriptan	Rizatriptan Benzoate	36	suppressed
Azithromycin	Azithromycin	35	28
Ozempic	Semaglutide	35	suppressed
Fluconazole	Fluconazole	34	13
Doxycycline Monohydrate	Doxycycline Monohydrate	33	20
Propranolol Hcl	Propranolol Hcl	32	14
Propranolol Hcl Er	Propranolol Hcl	31	13
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Amoxicillin	Amoxicillin	28	16
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Clindamycin Hcl	Clindamycin Hcl	27	14
Fluoxetine Hcl	Fluoxetine Hcl	26	11
Carvedilol	Carvedilol	25	suppressed
Colchicine	Colchicine	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	23
Ondansetron Hcl	Ondansetron Hcl	25	15
Terbinafine Hcl	Terbinafine Hcl	25	21
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	11
Hydrocortisone	Hydrocortisone	22	suppressed
Eliquis	Apixaban	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	14
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Ketoconazole	Ketoconazole	18	11
Ofloxacin	Ofloxacin	18	16
Xarelto	Rivaroxaban	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Proctofoam-Hc	Hydrocortisone/Pramoxine	17	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Nitroglycerin	Nitroglycerin	16	12
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Nystatin	Nystatin	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Digoxin	Digoxin	14	suppressed
Estradiol	Estradiol	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Metronidazole	Metronidazole	14	11
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Galantamine Hbr	Galantamine Hbr	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Bicalutamide	Bicalutamide	11	suppressed
Diazepam	Diazepam	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Klor-Con 10	Potassium Chloride	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error